Disclosed herein are substituted cyclohexanone-based NMDA receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
本文揭示了基于取代环己酮的Formula I NMDA受体调节剂,其制备方法,相应的药物组合物以及使用方法。
PYRIDAZINE AND PYRIDINE DERIVATIVES AS NAMPT INHIBITORS
申请人:AbbVie Inc.
公开号:EP2847181A1
公开(公告)日:2015-03-18
[EN] PYRIDAZINE AND PYRIDINE DERIVATIVES AS NAMPT INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDAZINE ET PYRIDINE EN TANT QU'INHIBITEURS DE NAMPT
申请人:ABBVIE INC
公开号:WO2013170115A1
公开(公告)日:2013-11-14
Disclosed are compounds of formula (IC), or a therapeutically acceptable salt thereof which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.